Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00406510 · ClinicalTrials.gov registry record · Phase 4
Comparison of Frequency of Use of Optive and Systane
A Phase 4 study, sponsored by Innovative Medical.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00406510: Completed Phase 4 study, sponsored by Innovative Medical.
NCT00406510 is a Phase 4 study that has completed, run by Innovative Medical. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00406510, a Phase 4 study, has completed, sponsored by Innovative Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
The purpose of this study is subjectively compare duration of action between Optive and Systane.
Interventions
- DRUG Optive, Systane
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 4 |
What the finished NCT00406510 record still lists
NCT00406510 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Optive, Systane is the first listed.
NCT00406510 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00406510 about?
NCT00406510 is a clinical study titled "Comparison of Frequency of Use of Optive and Systane". The purpose of this study is subjectively compare duration of action between Optive and Systane.
What is the current status of trial NCT00406510?
This trial is currently completed. It is a Phase 4 study.
What interventions are being tested in trial NCT00406510?
The interventions under investigation include: Optive, Systane (DRUG).
Who is sponsoring clinical trial NCT00406510?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.